Abstract
P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The MDR cells were approximately 9-fold more resistant to the anticancer drug doxorubicin than their parental wild-type MDA-MB-435wt (WT) cells. Doxorubicin accumulation in the MDR cells was only 19% of that in the WT cells. The net uptake of doxorubicin in the nuclei of the MDR cells was 2-fold lower than that in the nuclei of the WT cells. Pgp inhibitors verapamil, cyclosporine A, or PSC833 increased doxorubicin accumulation in the MDR cells up to 79%, and it reversed drug resistance in these cells. In living animals, doxorubicin accumulation in MDA-MB-435mdr xenograft tumors was 68% of that in the wild-type tumors. Administration of verapamil, cyclosporine A, or PSC833 before doxorubicin treatment of the animals increased doxorubicin accumulation in the MDR tumors up to 94%. These studies have added direct in vitro and in vivo information on the capacity of the transporter protein Pgp to efflux doxorubicin and on the reversal of MDR by Pgp inhibitors in resistant cancer cells.
Footnotes
-
This study was supported by Grant CA96839-01 from the National Cancer Institute.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.127704.
-
ABBREVIATIONS: Pgp, P-glycoprotein; MDR, multidrug resistance; PBS, phosphate-buffered saline; MRP, multidrug resistant protein; CsA, cyclosporine A; ABC, ATP-binding cassette transporters; VX-710, biricodar; PSC 833, valspodar; ONT-093 (OC144-093), 2,4,5-trisubstituted imidazoles.
-
↵1 Current affiliation: Cellular Imaging Laboratory, Lead Generation/Optimization Biology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana.
-
↵2 Current affiliation: Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio.
- Received June 25, 2007.
- Accepted October 17, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|